KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silicon Laboratories (SLAB) Gains from Sales and Divestitures (2016 - 2023)

Historic Gains from Sales and Divestitures for Silicon Laboratories (SLAB) over the last 12 years, with Q4 2023 value amounting to $416000.0.

  • Silicon Laboratories' Gains from Sales and Divestitures rose 1005.29% to $416000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $416000.0, marking a year-over-year increase of 1005.29%. This contributed to the annual value of $416000.0 for FY2023, which is 1005.29% up from last year.
  • Latest data reveals that Silicon Laboratories reported Gains from Sales and Divestitures of $416000.0 as of Q4 2023, which was up 1005.29% from $378000.0 recorded in Q4 2022.
  • Silicon Laboratories' 5-year Gains from Sales and Divestitures high stood at $639000.0 for Q4 2019, and its period low was $378000.0 during Q4 2022.
  • For the 4-year period, Silicon Laboratories' Gains from Sales and Divestitures averaged around $496200.0, with its median value being $502000.0 (2022).
  • As far as peak fluctuations go, Silicon Laboratories' Gains from Sales and Divestitures tumbled by 2470.12% in 2022, and later skyrocketed by 1005.29% in 2023.
  • Over the past 4 years, Silicon Laboratories' Gains from Sales and Divestitures (Quarter) stood at $639000.0 in 2019, then dropped by 14.55% to $546000.0 in 2021, then plummeted by 30.77% to $378000.0 in 2022, then grew by 10.05% to $416000.0 in 2023.
  • Its Gains from Sales and Divestitures was $416000.0 in Q4 2023, compared to $378000.0 in Q4 2022 and $502000.0 in Q1 2022.